CLINICAL_TRIALS
trial_result
· 2020-09-14
Clinical Trial Update: A Bioavailability Study of DFD-03 Compared to Tazorac® in Patients With Moderate Acne Vulgaris [Phase 2]
Summary
Phase 2 bioavailability study comparing DFD-03 with Tazorac in moderate acne vulgaris completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dr. Reddy's Laboratories Limited | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED | Results posted: 2020-09-14